Novorex
Latest round
- Series B
Last raised
- Apr 2026
Total raised
- $23M
Investors
- 14
About Novorex
Founded in 2020 and based in Gyeonggi-do, South Korea, Novorex Inc. is focusing on new drug development to treat oncology and neurology diseases, particularly strengthens small-molecule new drugs using the three-dimensional structure of proteins and molecular calculations. In 2020, the company opened its Seoul Research Center and established corporate research institute. In 2021, its Jeongeup Branch and Pangyo Research Center were established and an application to be a military service exception company was filed. In April 2026, Novorex Inc. The company created drug development systems called Seamless Drug Discovery, Deep Designer, and Novo Picker.
Who invested in Novorex
14 investors across 3 rounds
See all investors in Novorex
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Novorex
Who invested in Novorex?
Novorex has 14 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Novorex raised?
Novorex has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Novorex last raise money?
Novorex's most recent round on record is a Series B, in Apr 2026.
What does Novorex do?
Founded in 2020 and based in Gyeonggi-do, South Korea, Novorex Inc.
Where is Novorex headquartered?
Novorex is headquartered in Seongnam, South Korea.
Which VCs invest in companies like Novorex?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Novorex's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Novorex? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.